• Return to Headlines

Shares of Accelerate Diagn Rank the Lowest in Terms of Sales per Share in the Life Sciences Tools & Services Industry (AXDX, PACB, FLDM, NEO, NSTG)

By David Diaz

Below are the three companies in the Life Sciences Tools & Services industry with the lowest sales per share. Sales per share is a valuable metric in comparing relative value for companies in the same industry.

Accelerate Diagn ranks lowest with a sales per share of $0.08. Following is Pacific Bioscien with a sales per share of $0.78. Fluidigm Corp ranks third lowest with a sales per share of $2.90.

Neogenomics Inc follows with a sales per share of $3.19, and Nanostring Techn rounds out the bottom five with a sales per share of $4.89.

SmarTrend is monitoring the recent change of momentum in Accelerate Diagn. Please refer to our Company Overview for the results of our proprietary technical indicators that have been scanning shares of Accelerate Diagn in search of a potential trend change.

Keywords: lowest sales per share accelerate diagn pacific bioscien fluidigm corp neogenomics inc nanostring techn

Ticker(s): AXDX PACB FLDM NEO NSTG